InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: None

Friday, 07/12/2013 5:07:38 PM

Friday, July 12, 2013 5:07:38 PM

Post# of 5874
IMUC is definitely getting lot of attention on two counts:

1. CLDX run-up based on their immunotherapy for Brian & Breast cancers
2. ICT-107 trial patients website continue to eschew good indicators for promising results potential similar to PI.

If PII results are anywhere close to what we have seen in single arm PI, $20 to $30 pps is not out of question.

IMUC could very well become SRPT